Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

5 clinical studies listed.

Filters:

Peptides

Tundra lists 5 Peptides clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT07528469

The Effects of PeptiStrong and Whey on Muscle Function In Older Adults

Examining the effects of PeptiStrong and protein on muscle function in older adults

Gender: All

Ages: 60 Years - 85 Years

Updated: 2026-09-28

Healthy Ageing
Protein Supplementation
Muscle Health
+4
RECRUITING

NCT07451769

Selective Activation of the Adrenomedullin Receptors in Migraine

Adrenomedullin is a neuropeptide implicated in the pathogenesis of migraine. This study investigates whether its administration, after pre-treatment with erenumab (a CGRP-receptor blocking monoclonal antibody), can trigger migraine attacks in individuals with migraine without aura.

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-08-28

Migraine
Brain Diseases
Central Nervous System Diseases
+5
RECRUITING

NCT07583654

Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors

The goal of this phase 1 clinical trial is to evaluate the safety, tolerability, and preliminary antitumor activity of a peptide-delivered IL-22BP biotherapy in patients with advanced solid tumors. The main questions it aims to answer are: Is the IL-22BP formulation safe and tolerable? Does the IL-22BP formulation show preliminary antitumor activity?

Gender: All

Ages: 18 Years - 70 Years

Updated: 2026-07-14

1 state

mRNA Vaccine
Solid Tumor Cancer
Peptides
+1
NOT YET RECRUITING

NCT07340788

Amylin-Induced Migraine Attacks Without Aura

Pramlintide is a peptide analogue of human amylin which is a vasoactive signaling molecule involved in the pathogenesis of migraine. This study investigates whether pramlintide induces migraine attacks without aura in people with migraine without aura.

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-01-14

Headache Disorders, Primary
Headache Disorders
Brain Diseases
+15
NOT YET RECRUITING

NCT07340775

Hypersensitivity to Amylin in Post-Traumatic Headache

Pramlintide is a peptide analogue of human amylin which is a vasoactive substance involved in the pathogenesis of headache. This study investigates whether pramlintide induces migraine-like headache in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-01-14

Headache Disorders, Secondary
Brain Diseases
Headache Disorders
+14